RGS2 and Alzheimer disease: Our qRT-PCR study detected a 1.6-fold decrease in the RGS2 mRNA levels in the whole blood of MCI patients compared to CTRL, supporting previous results obtained from LCLs derived from AD patients, and microarray data from the blood of MCI and AD patients.